- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$1.61 BnMarket Estimate, 2026
$1.79 BnMarket Forecast, 2034
$3.99 BnCAGR, 2026–2034
10.59%Executive Summary: North America Balloon Catheter Market
- Market Scope: Regional analysis of the North American balloon catheter sector, covering product categories, raw material frameworks, disease indications, healthcare end-users, and country-level dynamics.
- Market Valuation: Valued at USD 1.61 billion in 2025, reaching USD 1.79 billion in 2026, and projected to expand to USD 3.99 billion by 2034, growing at a robust CAGR of 10.59% from 2026 to 2034.
- Primary Growth Drivers: Rising prevalence of cardiovascular diseases, growing geriatric population adopting drug-coated balloons, technological advancements in medical manufacturing, and favorable reimbursement policies.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Product Type | Normal Balloon Catheter (dominant market share driven by widespread use in standard angioplasty and routine clinical procedures) | Drug Eluting Balloon Catheter (fastest-growing due to targeted drug delivery advantages and expedited recovery benefits) |
| By Raw Material | Nylon (major market share owing to high tensile strength, flexibility, and compliance in vascular navigation) | Polyurethane (expanding rapidly due to high biocompatibility and diverse mechanical properties for specialized surgeries) |
| By Disease Indication | Coronary Artery Disease (captured the largest share due to rising cardiovascular disease incidence among adults) | Peripheral Vascular Disease (growing rapidly driven by increasing elderly demographics and vascular complications) |
| By End User | Public & Private Hospitals (leading volume share supported by advanced surgical infrastructure and emergency cardiac care) | Ambulatory Surgical Centers (fastest growth fueled by preference for outpatient procedures and shorter recovery times) |
| By Country | United States (market leader backed by robust product portfolios, advanced R&D, and major manufacturing facilities) | Canada (high-growth potential driven by expanding clinical trial centers and preference for minimally invasive surgeries) |
Major Market Players & Industry Landscape
Market Structure: Highly consolidated healthcare technology landscape characterized by strong regulatory compliance, continuous innovation, strategic mergers, and robust collaboration among medical device manufacturers.
Key Companies: B. Braun Melsungen AG, Abbott Vascular, Terumo Medical Corp., Medtronic, Biosensors International Ltd., Boston Scientific, Goodman, Cordis, MicroPort Scientific Corp., Simeks Medical, and AngioScore, Inc.
Download Free Sample Report
North America Balloon Catheter Market Size
The North America Balloon Catheter Market is projected to grow from USD 1.61 billion in 2025 to USD 1.79 billion in 2026 and reach USD 3.99 billion by 2034, registering a CAGR of 10.59% during the forecast period from 2026 to 2034.
The growing patient population suffering from cardiovascular diseases across North America is fuelling the demand for balloon catheters and driving the North American market. In America, one in twenty adults aged above 20 years may experience cardiovascular issues in their lifetime. The use of balloon catheters is a common practice during catheterization procedures to widen narrow openings in the body. Balloon angioplasty is a procedure for patients with coronary artery diseases or heart attacks and is employed to open narrowed or blocked arteries.
The growing geriatric population in the North American region further boosts the growth rate of the North American market. The drug-coated balloons are a widely adopted technique for targeted drug delivery to expedite recovery for people aged. Older populations are more susceptible to surgical procedures, making drug-coated balloons a safe and effective treatment for coronary lesions in this demographic. This approach minimizes the bleeding risk in people, resulting in the increased adoption of balloon catheters and contributing to regional market growth.
The growing advancements in manufacturing balloon catheter devices and the rising focus of manufacturers on creating balloon catheters with diverse materials to cater to the different surgical requirements propel the growth of the North American balloon catheter market. The growing number of applications of balloon catheters in the healthcare sector further fuels the market's growth rate in North America. Notably, Foley bulbs, utilized for cervical dilation during induced labor, exemplify the efficacy of these devices. The procedure involves inserting a catheter into the cervix and applying pressure using a saline solution, sometimes with medication. Additionally, rising investments in research and development, approvals of novel devices, support from healthcare organizations, and favorable reimbursement policies contribute to market progress in North America.
The high cost of balloon catheter devices and procedures, challenges related to skilled professionals, awareness, FDA recalls, infrastructure and product approval timelines majorly hamper the growth of the balloon catheter market in North America. Complications such as leakage, misplacement, infection, bleeding, and stomach cramps further impede the regional market growth.
MARKET SEGMENTATION
This research report on the North America Balloon Catheter Market has been segmented and sub-segmented into the following categories
North America Balloon Catheter Market - By Product Type
- Cutting Balloon Catheter
- Scoring Balloon Catheter
- Normal Balloon Catheter
- Drug Eluting Balloon Catheter
- Stent Graft Balloon Catheter
North America Balloon Catheter Market - By Raw Material
-
Polyurethane
-
Nylon
North America Balloon Catheter Market - By Disease Indication
-
Coronary Artery Disease
-
Peripheral Vascular Disease
North America Balloon Catheter Market - By End User
-
Ambulatory Surgical Centers
-
Cardiac Catheterization Laboratories
- Public Hospitals & Private Hospitals
North America Balloon Catheter Market - By Country
-
US
- Canada
- Rest of North America
Regional Analysis
North America held the largest share of the global market in 2023 and the domination of the North American region in the worldwide market is expected to continue throughout the forecast period. Factors such as the growing investments in healthcare infrastructure, increased healthcare spending by the population and the strong presence of key market players drive the growth of the North American market. Government regulations and hospitals' widespread adoption of balloon catheter procedures also contribute to market growth.
The U.S. had the leading share of the North American market in 2023 and is predicted to hold the dominating share of the North American market throughout the forecast period owing to the robust portfolio of new catheter balloon products, supported by expanding manufacturing facilities, strategic mergers and acquisitions, and effective marketing campaigns.
Canada is anticipated to account for a considerable share of the North American market during the forecast period owing to the growing number of clinical trial centers and the rising preference for minimally invasive surgeries. Balloon catheter procedures, performed through small incisions, offer reduced hospital stays and faster recovery times compared to open surgeries.
KEY MARKET PLAYERS
Promising Companies leading the North America Balloon Catheter Market Profiled in the Report are B. Braun Melsungen AG, Abbott Vascular, Terumo Medical, Corp., Medtronic, Biosensors International, Ltd., Boston Scientific, Goodman, and Cordis.MicroPort Scientific, Corp., Simeks Medical, and AngioScore, Inc.